Clinical trial
A Phase II Study to Compare Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus
NCT02586753 is registered in ClinicalTrials.gov with Mianyang Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study to Compare Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus
- Lead sponsor
- Mianyang Central Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- September 30, 2016
- Enrollment
- 2 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.